ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0713

IgG4-Related Disease as a Potencial Etiology of Idiopathic Constrictive Pericarditis

Edwin Ulises Cortez-Domínguez1, Gabriela Hernandez-Molina1, Norma Ofelia Uribe-Uribe2, María J Lizardo-Thiebaud2 and Eduardo Martin-Nares1, 1Department of Immunology and Rheumatology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico, 2Department of Pathology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico

Meeting: ACR Convergence 2023

Keywords: Fibrosing syndromes, Heart disease, IgG4 Related Disease, Miscellaneous Rheumatic and Inflammatory Diseases

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 12, 2023

Title: (0691–0721) Vasculitis – Non-ANCA-Associated & Related Disorders Poster I

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Constrictive pericarditis (CP) is a type of diastolic heart failure characterized by impaired cardiac filling due to the presence of an inelastic pericardium. Histologically, the pericardium exhibits fibrotic and thickened features. While tuberculosis remains the primary cause of CP in developing countries, idiopathic CP predominates in North America and Europe. The extent to which idiopathic CP patients may belong to the spectrum of IgG4-related disease remains unknown. Therefore, our objective was to determine the number of idiopathic CP patients meeting histopathological criteria for IgG4-RD.

Methods: Clinical records of patients with CP attended between 1987-2020 were reviewed. Those without a biopsy or with a known etiology of CP were excluded. Pericardial biopsies were analyzed in search of dense lymphoplasmacytic infiltrate, storiform fibrosis, and obliterative phlebitis. Immunohistochemistry for IgG and IgG4 was performed. The number of IgG+ and IgG4+ plasma cells and the IgG4/IgG ratio were determined according to the International Consensus on Pathology (ICP) of IgG4-RD. According to the ICP, cases were classified as highly suggestive, probable histopathological characteristics, or insufficient histopathological evidence. The Comprehensive Diagnostic Criteria for IgG4-RD (CDCI) and the 2019 ACR/EULAR classification criteria (AECC) were also applied. Clinical characteristics were extracted from the patients’ medical records.

Results: Sixty-six cases were reviewed, of which 10 had an identified etiology. Of the remaining 56, only 12 had a pericardial biopsy. All had been classified as idiopathic (Figure 1). Mean age of 43.5 ± 14.4 years; 9 were men. Regarding clinical behavior, all patients presented with signs and symptoms of heart failure. Six (50%) patients presented with effusive CP and 10 (83.3%) with chronic CP (non-mutually exclusive). Findings on electrocardiogram, echocardiogram, cardiac magnetic resonance imaging and cardiac computed tomography are summarized in Table 1. All patients underwent pericardiectomy, with glucocorticoid treatment administered to only one patient. At last follow-up, 3 (25%) patients had died.

Lymphoplasmacytic infiltrate was found in all, fibrosis in eight, and storiform fibrosis in only one case. Obliterative phlebitis was not found. In 2 cases the IgG stains were not assessable, so the IgG4/IgG ratio was calculated in 10 cases. The median number of IgG4+ plasma cells/HPF was 30.5 (IQR 16.5-41). The median IgG4/IgG ratio was 59.5% (IQR 27-66). All cases had >10 IgG4+ plasma cells/HPF while 7/10 (70%) had an IgG4/IgG ratio >40%. According to the ICP, 1 (8.3%) case was highly suggestive, 6 (50%) had probable histological characteristics, and 5 (41.6%) showed insufficient histopathological evidence. Seven (58.3%) were diagnosed as probable IgG4-RD according to the CDCI, but only one patient met 2019 AECC for atypical IgG4-RD.

Conclusion: A significant proportion of pericardial biopsies from patients with idiopathic CP display findings indicative of IgG4-RD and meet at least one set of diagnostic or classification criteria. Considering the implications for treatment, IgG4-RD should be considered when evaluating patients with CP.

Supporting image 1

Figure 1. Flowchart illustrating the inclusion criteria.

Supporting image 2

Table 1. Electrocardiographic and cardiac imaging findings.


Disclosures: E. Cortez-Domínguez: None; G. Hernandez-Molina: None; N. Uribe-Uribe: None; M. Lizardo-Thiebaud: None; E. Martin-Nares: None.

To cite this abstract in AMA style:

Cortez-Domínguez E, Hernandez-Molina G, Uribe-Uribe N, Lizardo-Thiebaud M, Martin-Nares E. IgG4-Related Disease as a Potencial Etiology of Idiopathic Constrictive Pericarditis [abstract]. Arthritis Rheumatol. 2023; 75 (suppl 9). https://acrabstracts.org/abstract/igg4-related-disease-as-a-potencial-etiology-of-idiopathic-constrictive-pericarditis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2023

ACR Meeting Abstracts - https://acrabstracts.org/abstract/igg4-related-disease-as-a-potencial-etiology-of-idiopathic-constrictive-pericarditis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology